
Waiving COVID Patents – Interview with Ulrich Storz – G1/21 of the EBoA at the EPO – New USPTO Director – Episode 123 – IP Fridays
IP Fridays - your intellectual property podcast about trademarks, patents, designs and much more
00:00
The Development of Mana Vexan
The concept of using m rna as an vacin has been introduced in two thousand, 22000. 20 years ago, by a mingmaner who was the founder of of ofkuba. He discovered inma wiks, yes. Then there was katheline carico from university of pennsylvania,. Found out that if you use specific euridine varians, mitussut uridine, then you make it and then you make amaran avx. Since less immunogenic, e not imunogenic, but less m so thatttat that the body reaction triggers on an immune reaction on the produced protein, but does not direct itself against the mana per c m.
Transcript
Play full episode